|Day Low/High||65.91 / 68.16|
|52 Wk Low/High||28.20 / 76.42|
Six charts showing signs of smart money footprints.
The biotech company plans to commercialize its treatment for AL amyloidosis, a disease that causes protein to build up in the blood.
Karyopharm Therapeutics falls 18%; Lexicon rises on drug approval.
Data Previously Presented in 2015 at 19th International Congress of Parkinson's Disease and Movement Disorders